Post by
Journeytc on Jul 31, 2024 1:02pm
Quarterly Meeting
I look forward to the quarterly update tomorrow and incites given without Matt. Specifically whats on the critical path for Breast Cancer and Pancreatic trials. When can we expect enrollments to begin and do they intend to strike a partnership? beforehand? Im not holding my breath.
Share volumes traded are pathetically low. Markets dont like the companies track record. ONC is a ship without a rudder. Will new management change history? Markets need transparency and intent to deliver. Arm waving, science talk and trial results wont cut it.
Comment by
13X2413 on Jul 31, 2024 3:03pm
Every update, fireside chat and various other updates from the company has resulted in additional downward pressure on share prices. Don't expect anything different. Judging by the lack of interest from real investors, I'm not the only one.